Codex DNA BioXp mRNA Synthesis Kits With CleanCap Reagent AG
Dec 01, 2021
Codex DNA has launched its BioXp mRNA synthesis kits with integrated CleanCap Reagent AG, a proprietary mRNA capping technology from TriLink BioTechnologies. The new kits allow users to achieve large yields of high-quality, capped mRNA. Specifically, customers can now generate up to 16 biologically active mRNA constructs with a median yield of 10 micrograms each from de novo synthesized and error-corrected genes in a single automated run.